Latest Breaking News On - Professor barenholz - Page 2 : comparemela.com

Innocan Pharma Corporation: Innocan Pharma Files PCT Patent Application for Diabetic Symptoms

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - July 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has

Israel generalSachsen anhaltUnited statesTel avivIris bincovichInnocan pharmaCompany or innocanInnocan pharma corporationStraits researchInnocan pharma ltdEuropean unionHebrew university of jerusalemAlberta newsfile corpInternational diabetes federationTel aviv universityPharma corporation

Innocan Pharma Corporation: Former Dexcel Pharma Analytical Chemist to Join Innocan Pharma LPT Pharmaceutical R&D Team as it is Moving Forward with the LPT Development

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - July 12, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it

Israel generalTel avivHebrew universityIris bincovichChezy barenholzDexcel pharmaInnocan pharmaDevelopment company yissumCompany or innocanDrug administrationInnocan pharma corporationLiposome research departmentInnocan pharma ltdHebrew university of jerusalemAlberta newsfile corpTel aviv university

Former Dexcel Pharma Analytical Chemist to Join Innocan Pharma LPT Pharmaceutical R&D Team as it is Moving Forward with the LPT Development

Former Dexcel Pharma Analytical Chemist to Join Innocan Pharma LPT Pharmaceutical R&D Team as it is Moving Forward with the LPT Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel generalTel avivHebrew universityIris bincovichChezy barenholzDexcel pharmaInnocan pharmaDevelopment company yissumCompany or innocanDrug administrationInnocan pharma corporationLiposome research departmentInnocan pharma ltdHebrew university of jerusalemAlberta newsfile corpTel aviv university

Innocan Pharma Corporation: Innocan Reports Positive Results from Recent Preclinical Trial on Epileptic Seizures On a Dog using LPT: Since The Last LPT injection, Paco (dog) Has Not Had a Seizure for Over 10 weeks

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - July 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce positive results

Israel generalTel avivHebrew universityIris bincovichChezy barenholzInnocan pharmaDevelopment company yissumCompany or innocanInnocan pharma corporationLiposome research departmentMarket researchInnocan pharma ltdHebrew university of jerusalemAlberta newsfile corpTel aviv universityYissum research

Innocan Pharma Corporation: Innocan Reports Successful Preclinical Dog-Trial Results Regarding Pain Management: It Was as If a New Dog Came into Our Lives

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - June 24, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce successful

Israel generalTel avivHebrew universityIris bincovichChezy barenholzInnocan pharmaDevelopment company yissumCompany or innocanInnocan pharma corporationLiposome research departmentMarket researchInnocan pharma ltdHebrew university of jerusalemAlberta newsfile corpTel aviv universityYissum research